Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
Find Funding Opportunities
NIH Extramural Response to Natural Disasters and Other Emergencies
In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee. Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-AR-25-004
Tuesday, February 13, 2024
Notice Type: NOT
Notice of Change: Extension of PAR-21-153 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-039
Thursday, February 8, 2024
Notice Type: NOT
The purpose of this notice is to inform applications of an extension to PAR-21-153 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)" by one council round.
Notice of Change: Extension of PAR-21-233 "Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System U44"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-050
Thursday, February 8, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of extensions to PAR-21-233 "Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System U44."
Notice of Change to Award Budget for RFA-NS-24-014 "NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)"
Expiration Date: Saturday, January 1, 2028
NOFO Number: NOT-NS-24-055
Tuesday, February 6, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of a clarification to the Award Budget for RFA-NS-24-014 "NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)".
Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-056
Tuesday, February 6, 2024
Notice Type: NOT
The purpose of this notice is to inform applications of an extension to PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)" by one council round.
Notice to Rescind NOT-NS-24-038 "Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-057
Tuesday, February 6, 2024
Notice Type: NOT
The purpose of this notice is rescind NOT-NS-24-038 "Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)", effectively immediately.
NINDS Requirements for Induced Pluripotent Stem Cell Development and Resource Sharing
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-019
Thursday, February 1, 2024
Notice Type: NOT
The purpose of this Notice is to update the research community to the current NINDS guidelines for development and distribution of human induced pluripotent stem cells (iPSCs) through theNINDS Human Cell and Data Repository (NHCDR).
Notice to Rescind NOT-NS-14-032 "NINDS Requirements for Induced Pluripotent Stem Cell Development and Resource Sharing"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-058
Thursday, February 1, 2024
Notice Type: NOT
The purpose of this notice is to rescind NOT-NS-14-032 "NINDS Requirements for Induced Pluripotent Stem Cell Development and Resource Sharing". This notice is being replaced with NOT-NS-24-019 "NINDS Requirements for Induced Pluripotent Stem Cell Development and Resource Sharing".
Notice of Change: Extension of PA-21-219: Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-054
Wednesday, January 31, 2024
Notice Type: NOT
Extending this NOFO until November 2024.
Notice of Change: Extension of RFA-NS-24-028 - BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-025
Tuesday, January 30, 2024
Notice Type: NOT
The purpose of this notice is to extend RFA-NS-24-028BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed) by one additional council round.
An additional receipt date, August 21, 2024, has been added and the new expiration date is August 22, 2024.